MiniMed Group, Inc. Common Stock
MMED
Rank in Stocks
#3404
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Share Price
$17.87
Last synced: 2026-10-21
Market Cap
$5.03B
Change (1 day)
2.14%
Change (1 year)
-
Country
US
Trade MiniMed Group, Inc. Common Stock (MMED)
Category
Healthcare
Revenue for MiniMed Group, Inc. Common Stock (MMED)
Revenue in Oct 2026 TTM: 0
According to MiniMed Group, Inc. Common Stock latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MiniMed Group, Inc. Common Stock from 2023 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2025 | $2.72B | 9.96% |
| 2024 | $2.47B | 9.98% |
| 2023 | $2.25B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $2.58B | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 0.00 | - |
IL
|
|
| $249.73M | - |
US
|
